SABS, SABSW · CIK 0001833214 · operating
SAB Biotherapeutics, Inc. (SABS) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $187 million, SAB Biotherapeutics, Inc. is a micro-cap company. The stock currently trades at $4.07, down 0.73% today, with a 52-week range of $1.00–$6.60.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.68 | $-3.68 | +51.8% | |
| 2023 | $-7.64 | $-7.64 | -1676.7% | |
| 2022 | — | $-0.43 | +31.7% | |
| 2021 | $-0.63 | $-0.63 | — | |
| 2020 | — | — | — |